# Episode 419: Pharmacology 101: Immunomodulators

Page: https://stenobird.com/podcast/the-ons-podcast-1126448/episode-419-pharmacology-101-immunomodulators
Text version: https://stenobird.com/podcast/the-ons-podcast-1126448/episode-419-pharmacology-101-immunomodulators.md
Podcast: [The ONS Podcast](https://stenobird.com/podcast/the-ons-podcast-1126448)
Published: 2026-06-12T07:00:00+00:00
Episode link: https://onsvoice.libsyn.com/episode-418-pharmacology-101-immunomodulators
Audio file: https://traffic.libsyn.com/secure/onsvoice/418_-_Immunomodulators_-_EDITED.mp3?dest-id=557038
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-419-pharmacology-101-immunomodulators
Duration seconds: 2666

## Resource

"Until immunomodulators, patients [with myeloma] did not have a great overall survival rate. But when we introduced lenalidomide, we started seeing our patients have life expectancies between five and seven years—which was unheard of prior to these immunomodulators going forward. I think it's promising and allows patients to have quality of life versus therapy of life," ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS ® , TCTCN ™ , oncology clinical specialist at ONS, during a conversation about immunomodulators. Music Credit: " Fireflies and Stardust " by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 12, 2027. Daniel Verina is on the speakers' bureau for Johnson & Johnson, GlaxoSmithKline, and Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of immunomodulators to treat cancer. Episode Notes Complete this evaluation for free NCPD . ONS Podcast ™ episodes: Pharmacology 101 series Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 386: Interprofessional Navigation and the Oral Anticancer Medication Care Compass Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy ONS Voice articles: Maintain Oral Adherence With ONS Guidelines™ Multiple Myeloma Prevention, Screening, Treatment, a…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-419-pharmacology-101-immunomodulators/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-ons-podcast-1126448/episode-419-pharmacology-101-immunomodulators.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.